Skip to main content
. 2018 Sep 8;9(18):3352–3360. doi: 10.7150/jca.25530

Fig 1.

Fig 1

Flowchart of the study design. NPC, nasopharyngeal carcinoma; EBV DNA, pretreatment plasma Epstein-Barr viral deoxyribonucleic acid; IMRT, intensity-modulated; OS, overall survival; PFS, progression-free survival; LRFS, loco-regional recurrence-free survival; DMFS, distant metastasis-free survival; McNemar: analysis of variance; SD, standard deviation